NDAORALFOR SOLUTION
Approved
Aug 2013
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
Mechanism of Action Enalapril, after hydrolysis to enalaprilat, inhibits angiotensin-converting enzyme (ACE) in human subjects and animals. ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. Angiotensin II also stimulates…
Loss of Exclusivity
LOE Date
Nov 6, 2032
81 months away
Patent Expiry
Nov 6, 2032
Company
R-Pharm US
NJ - Princeton